3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
1
Conditions
Lymphoma, T-Cell, Peripheral
1
Lymphoma, T-Cell
1
Interventions
Cisplatin
508
Cyclophosphamide
360
Carboplatin
352
Radiotherapy
350
Capecitabine
328
Paclitaxel
324
Oxaliplatin
323
Gemcitabine
320
Docetaxel
310
Fluorouracil
282
Drug Therapy
243
apatinib
242
Bevacizumab
228
camrelizumab
214
Etoposide
200
Irinotecan
175
Doxorubicin
175
Leucovorin
161
Dexamethasone
160
sintilimab
142
pembrolizumab
138
Pemetrexed
136
Cytarabine
136
anlotinib
135
toripalimab
130
Neoadjuvant Therapy
122
S 1 (combination)
120
Vincristine
119
Rituximab
116
Radiosurgery
116
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Interventional
×
Flavin-Adenine Dinucleotide
×
Clear all
NCT00840385
2010-09-15
FAD
Fudan University
Phase 2
Unknown
30 enrolled